GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultimovacs ASA (OSL:ULTI) » Definitions » Net Interest Margin (Bank Only) %

Ultimovacs ASA (OSL:ULTI) Net Interest Margin (Bank Only) %


View and export this data going back to 2019. Start your Free Trial

What is Ultimovacs ASA Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.


Ultimovacs ASA (OSL:ULTI) Business Description

Industry
Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, 0379
Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.